IMMUNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2021-12-28 乌云背后的幸福线

SD/SEM是什么，有什么区别？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2021-12-27 学医的彭于晏

为什么期刊要求用三线表/使用三线表的意义何在？

85 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2019-09-17 1e0cd631m61(暂无匿称)

一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表:
非常好的期刊，编辑和审稿人都很nice，好评

ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评

147 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2019-01-15 xs菜

周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高

174 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2016-07-11 oo902

杂志还可以，一审给了些意见

333 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2020-08-18 ms3000000984468914

这个杂志一审多久啊？有没有人投过这个杂志？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2023-11-09 ms5000000099345545 来自北京

偏重的研究方向：免疫学;感染
经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。

31 0

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2023-10-07 ms6000001806700923 来自广东省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：免疫;免疫学
经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。

48 0

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2023-07-18 ms4000000449376470 来自瑞典

偏重的研究方向：免疫学
经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。

58 0

[GetPortalCommentsPageByObjectIdResponse(id=1091801, encodeId=2779109180158, content=SD/SEM是什么，有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091802, encodeId=c8611091802e6, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576458, encodeId=2f315e645837, content=一定要是免疫相关的，免疫性疾病上皮屏障相关的可以吗？ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, beContent=ztznn 2019-08-23 00:00:00 发表: 非常好的期刊，编辑和审稿人都很nice，好评, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c26d1931261, createdName=1e0cd631m61(暂无匿称), createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565601, encodeId=af1656560175, content=周六投的周二就给拒了然后建议了别的3个杂志感觉编辑态度很好效率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/7ACF56F12F6E6C6EC56608473039E693/100, createdBy=14e22040105, createdName=xs菜, createdTime=Tue Jan 15 10:35:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524695, encodeId=ebdf52469555, content=杂志还可以，一审给了些意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Mon Jul 11 20:36:00 CST 2016, time=2016-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810547, encodeId=15b981054e0e, content=这个杂志一审多久啊？有没有人投过这个杂志？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b835401266, createdName=ms3000000984468914, createdTime=Tue Aug 18 22:28:25 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167558, encodeId=8436216e55827, content=偏重的研究方向：免疫学;感染 经验分享：投稿几天就显示under reivew状态，等了2个月没动静，发邮件催稿，编辑说没有找到合适的审稿人，没有送外审。。。，然后直接拒稿信就发过来了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aee59018635, createdName=ms5000000099345545, createdTime=Thu Nov 09 13:55:13 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161317, encodeId=b744216131ec8, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：免疫;免疫学 经验分享：文章一审二审加起来差不多一年被拒绝。可能换了不同审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c328336161, createdName=ms6000001806700923, createdTime=Sat Oct 07 11:51:20 CST 2023, time=2023-10-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2148534, encodeId=44fa21485347a, content=偏重的研究方向：免疫学 经验分享：这个杂志真的恶心，投稿后过了一个月编辑拒稿，没送外审。奇葩的是没过多久收到一个非SCI杂志的邮件，让我们投，还附带了我们的标题，摘要，和所有作者的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe58576500, createdName=ms4000000449376470, createdTime=Tue Jul 18 01:06:50 CST 2023, time=2023-07-18, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2119430, encodeId=8b39211943004, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770b8405142, createdName=ms5000000214193900, createdTime=Tue Mar 14 22:56:38 CST 2023, time=2023-03-14, status=1, ipAttribution=广东省)]

2023-03-14 ms5000000214193900 来自广东省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：还

46 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务